Istesso Limited
Istesso is pioneering disease resolution therapies aimed at treating chronic diseases by rebuilding damaged tissue, potentially reversing disease progression and restoring normal function.
Founded: 5 May 2017
Industries:
72190 - Other research and experimental development on natural sciences and engineering
Website: istesso.co.uk
Phone: 01625545745
Email: info@istesso.co.uk
Location: London
Products & Services
• autoimmunity
• chronic diseases
• disease resolution
• fibrosis
• ist004 for neuroprotection/autoimmunity
• leramistat for idiopathic pulmonary fibrosis (ipf)
• leramistat for rheumatoid arthritis
• mbs2687 for autoimmune, neuroprotection/fibrosis
• neuroprotection
• pharmaceutical company
• programmed disease-resolving drugs
Financial Snapshot
Cash in Bank
Turnover
EBITDA
Gross Profit
Total Liabilities
Employees
Unlock financial data with Pro Start Free Trial →
People
Officers
6
Shareholders
26
Controllers (PSC)
3
Ip2ipo Services Limited
Corporate Director • United Kingdom
Lisa Patel
Director • British • Lives in United Kingdom • Born in May 1973
Samuel Cameron Williams
Director • British • Lives in United Kingdom • Born in Apr 1969
Peter Vance Allen
Director • British • Lives in United Kingdom • Born in Mar 1956
David Keith Peters
Director • British • Lives in United Kingdom • Born in Jul 1938
Registered Office Address
2nd Floor 3 Pancras Square
Kings Cross
London
N1C 4AG
United Kingdom
Basic Information
LTD
5 May 2017
ENGLAND WALES
Yes
Industry Classification
72190
Company Attributes
N/A
N/A
N/A
N/A
Summary
9
Officers
3
PSCs
0
Filings